152
Participants
Start Date
March 8, 2023
Primary Completion Date
October 31, 2023
Study Completion Date
October 31, 2023
Tirzepatide
Administered SC
Endocrine and Metabolic Consultants, Rockville
Mountain View Clinical Research, Inc., Greenville
Endocrine Research Solutions, Inc., Roswell
East Coast Institute for Research, LLC, Jacksonville
Florida Institute For Clinical Research, LLC, Orlando
Velocity Clinical Research, Hallandale Beach, Hallandale
Velocity Clinical Research, Valparaiso, Valparaiso
Iowa Diabetes and Endocrinology Research Center, West Des Moines
Clinical Research Professionals, Chesterfield
Cotton O'Neil Clinic, Topeka
Conrad Clinical Research, Edmond
ClinPoint Trials, Waxahachie
North Texas Endocrine Center, Dallas
Consano Clinical Research, LLC, Shavano Park
Fiel Family and Sports Medicine PC, Tempe
Clinical Research of South Nevada, Las Vegas
Palm Research Center Tenaya, Las Vegas
Velocity Clinical Research, Huntington Park, Los Angeles
Velocity Clinical Research, Gardena, Gardena
Velocity Clinical Research, Huntington Park, Huntington Park
Valley Clinical Trials, Inc., Northridge
Dream Team Clinical Research, Pomona
New Hope Research Development, Corona
Scripps Whittier Diabetes Institute, San Diego
Metabolic Institute of America, Tarzana
CMR of Greater New Haven, LLC, Waterbury
New Tampa Health, Tampa
Georgia Clinical Research, Lawrenceville
Versailles Family Medicine, Versailles
Advanced Medical Research, Maumee
Texas Diabetes & Endocrinology, P.A., Austin
Memorial City Endocrine Consultants, Houston
Eli Lilly and Company
INDUSTRY